# FDA Inspection 874163 - Dong-Wan Kim, M.D., Ph.D. Seoul National University Hospital - March 26, 2014

Source: https://www.keypedia.com/records/fda_inspections/dong-wan-kim-md-phd-seoul-national-university-hospital/e1867ac4-10df-4026-88f4-21b50fa581e4
Source feed: FDA_Inspections

> FDA Inspection 874163 for Dong-Wan Kim, M.D., Ph.D. Seoul National University Hospital on March 26, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 874163
- Company Name: Dong-Wan Kim, M.D., Ph.D. Seoul National University Hospital
- Inspection Date: 2014-03-26
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 995342 - 2016-11-18](https://www.keypedia.com/records/fda_inspections/dong-wan-kim-md-phd-seoul-national-university-hospital/11398e8b-6aeb-43cd-88ee-7fa147f2d373)
- [FDA Inspection 728638 - 2011-05-20](https://www.keypedia.com/records/fda_inspections/dong-wan-kim-md-phd-seoul-national-university-hospital/c613a28f-6baf-49a2-8b92-8b00e5d9efac)

Company: https://www.keypedia.com/companies/dong-wan-kim-md-phd-seoul-national-university-hospital/2fc2b158-6586-4881-a045-12957852842a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c